Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Paradiso

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
Biochemical Pharmacology|June 9, 2004
The schedule-dependent enhanced cytotoxic activity of 7-ethyl-10-hydroxy-camptothecin (SN-38) in combination with Gefitinib (Iressa, ZD1839)Amalia Azzariti, Jian-Ming Xu, Letizia Porcelli, et al.
International Journal of Molecular Sciences|April 30, 2020
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast CancerStella D'Oronzo, Erica Silvestris, Angelo Paradiso, et al.
Virology|October 3, 2002
Human papillomavirus type 32 does not display in vitro transforming propertiesSandra Caldeira, Wen Dong, Pascal Tomakidi, et al.
BMC Cancer|March 24, 2012
Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosisAndrea Malfettone, Concetta Saponaro, Angelo Paradiso, et al.
Biochemical Pharmacology|January 15, 2008
Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cellsAmalia Azzariti, Letizia Porcelli, Giuliana Gatti, et al.
International Journal of Biological Sciences|February 13, 2019
Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of CancerRosa Divella, Antonio Mazzocca, Antonella Daniele, et al.
Current Drug Metabolism|March 26, 2011
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapyAmalia Azzariti, Letizia Porcelli, Anna Elisa Quatrale, et al.
Clinical Chemistry|April 24, 2003
External quality assurance program for PCR amplification of genomic DNA: an Italian experienceClaudia Casini Raggi, Pamela Pinzani, Angelo Paradiso, et al.
American Journal of Clinical Pathology|July 27, 2004
The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumabAnthony Rhodes, Duncan Borthwick, Rob Sykes, et al.
Breast Care (Basel, Switzerland)|September 18, 2010
Biomarkers for Early Cancer Detection - Methodological AspectsPaolo Verderio, Anita Mangia, Chiara M Ciniselli, et al.
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
Biochemical Pharmacology|June 9, 2004
The schedule-dependent enhanced cytotoxic activity of 7-ethyl-10-hydroxy-camptothecin (SN-38) in combination with Gefitinib (Iressa, ZD1839)Amalia Azzariti, Jian-Ming Xu, Letizia Porcelli, et al.
International Journal of Molecular Sciences|April 30, 2020
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast CancerStella D'Oronzo, Erica Silvestris, Angelo Paradiso, et al.
Virology|October 3, 2002
Human papillomavirus type 32 does not display in vitro transforming propertiesSandra Caldeira, Wen Dong, Pascal Tomakidi, et al.
BMC Cancer|March 24, 2012
Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosisAndrea Malfettone, Concetta Saponaro, Angelo Paradiso, et al.
Biochemical Pharmacology|January 15, 2008
Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cellsAmalia Azzariti, Letizia Porcelli, Giuliana Gatti, et al.
International Journal of Biological Sciences|February 13, 2019
Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of CancerRosa Divella, Antonio Mazzocca, Antonella Daniele, et al.
Current Drug Metabolism|March 26, 2011
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapyAmalia Azzariti, Letizia Porcelli, Anna Elisa Quatrale, et al.
Clinical Chemistry|April 24, 2003
External quality assurance program for PCR amplification of genomic DNA: an Italian experienceClaudia Casini Raggi, Pamela Pinzani, Angelo Paradiso, et al.
American Journal of Clinical Pathology|July 27, 2004
The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumabAnthony Rhodes, Duncan Borthwick, Rob Sykes, et al.
Breast Care (Basel, Switzerland)|September 18, 2010
Biomarkers for Early Cancer Detection - Methodological AspectsPaolo Verderio, Anita Mangia, Chiara M Ciniselli, et al.
Pageof 20